Missouri sues drugmakers, PBMs over insulin pricing

(By: Ella Jeffries for Becker’s Hospital Review)

The Missouri attorney general’s office has filed a lawsuit against 19 pharmacy benefit managers and drug manufacturers, alleging they conspired to inflate insulin prices and deceive consumers.

The lawsuit claims the defendants engaged in deceptive and unfair practices that caused life-sustaining insulin prices to soar in the state, according to court documents. The lawsuit, filed in St. Louis County Circuit Court, claims some manufacturers listed insulin at $300 to $400 per vial in Missouri, while selling the same drugs abroad for less than $5. Nearly 450,000 Missouri residents are uninsured, and approximately 18% of them are diabetic. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.